Skip to main content

Enveric Biosciences, Inc.

corporate_fare Company Profile

Enveric Biosciences, Inc.

ENVB·NASDAQ·Life Sciences·CIK 0000890821

Enveric Biosciences, Inc. was incorporated in Delaware in February 1994. The company's business history includes a reverse merger on May 26, 2015, with Ameri and Partners Inc., at which point the company changed its name to AMERI Holdings, Inc. The Ameri business was spun off on December 30, 2020. On the same date, the company completed a tender offer to acquire all outstanding common shares of Jay Pharma Inc., a Canada corporation, and subsequently changed its name to "Enveric Biosciences, Inc." On September 16, 2021, the company completed an amalgamation under the British Columbia Business Corporations Act, indirectly acquiring all outstanding securities of MagicMed Industries Inc., a corporation existing under the laws of the Province of British Columbia. Following this, the amalgamated corporation became an indirect wholly-owned subsidiary of Enveric Biosciences, Inc. The company's principal corporate office is located at 245 First Street, Riverview II, 18th Floor, Cambridge, MA 02142.

Enveric Biosciences, Inc. (NASDAQ:ENVB) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for ENVB at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • Enveric Biosciences Reports Positive Preclinical Data and Major IP Win Amidst Ongoing Capital Raises
  • Registers Shares for Resale from Warrants, Critical for Liquidity Amidst Going Concern Warning
  • Enveric Biosciences Initiates New $1.35 Million At-The-Market Offering Amidst Ongoing Capital Needs
  • Enveric Biosciences Finalizes $1.5M Registered Direct Offering at Premium to Market Price
  • Enveric Biosciences Secures $1.25M in Dilutive Offering with Warrants Amidst Ongoing Capital Needs

Financial Snapshot

Fiscal year ended December 31, 2025
Net Income
-$8.77M
Diluted EPS
-$36.24
Op. Cash Flow
-$8.14M
Operating Income
-$8.77M
Cash & Equivalents
$4.68M
Debt / Equity
0.00×
Shares Outstanding
1.06M sh
Source: 10-K · filed 2026-03-27 · accession 0001493152-26-013294
$1.61 -0.01% today
52-week range · as of 2026-08-14 $1.25 – $17.64
Market cap
$7.25M
Volume
158.6K (1.7× avg)
3-mo avg 95.5K
Live data · 2026-09-20 12:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed ENVB - Filings & News (Page 2)

ENVB
Mar 27, 2026, 5:25 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.88
Real-time Price: $1.61 info
Change: -$0.270 (-14%) info
Market Cap: $7.251M info
ENVB
Feb 09, 2026, 9:28 PM EST
Filing Type: S-1
Importance Score:
9
Price at Filing: $2.12
Real-time Price: $1.61 info
Change: -$0.5125 (-24%) info
Market Cap: $7.251M info
ENVB
Feb 06, 2026, 4:30 PM EST
Filing Type: 424B5
Importance Score:
9
Price at Filing: $2.37
Real-time Price: $1.61 info
Change: -$0.760 (-32%) info
Market Cap: $7.251M info
ENVB
Jan 28, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $3.45
Real-time Price: $1.61 info
Change: -$1.84 (-53%) info
Market Cap: $7.251M info
ENVB
Jan 28, 2026, 1:33 PM EST
Filing Type: 424B5
Importance Score:
8
Price at Filing: $3.46
Real-time Price: $1.61 info
Change: -$1.85 (-53%) info
Market Cap: $7.251M info
ENVB
Jan 09, 2026, 5:23 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $4.02
Real-time Price: $1.61 info
Change: -$2.41 (-60%) info
Market Cap: $7.251M info
ENVB
Jan 02, 2026, 8:26 AM EST
Filing Type: 424B3
Importance Score:
8
Price at Filing: $3.55
Real-time Price: $1.61 info
Change: -$1.94 (-55%) info
Market Cap: $7.251M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets